Research programme: AZM 145 - Alizyme
Alternative Names: AZM 145Latest Information Update: 16 Oct 2001
At a glance
- Originator Alizyme; University of Birmingham School of Medicine
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 16 Oct 2001 Discontinued-Preclinical for Diabetes mellitus in United Kingdom (PO)
- 19 Oct 2000 Alizyme is seeking partners for the programme (www.alizyme.com)
- 29 Oct 1998 New profile